<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05061836</url>
  </required_header>
  <id_info>
    <org_study_id>12345</org_study_id>
    <nct_id>NCT05061836</nct_id>
  </id_info>
  <brief_title>Effect of Using Dextrose-containing Intraoperative Fluid in Children</brief_title>
  <official_title>Effect of Using Dextrose-containing Intraoperative Fluid in Children: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The glucose-containing fluid was preferred for maintenance fluid in pediatric surgery to&#xD;
      prevent hypoglycemic events. This practice can lead to intraoperative hyperglycemia which can&#xD;
      induce osmotic diuresis and consequently dehydration and electrolyte disturbances.&#xD;
&#xD;
      As an anesthesiologist, the use of glucose-containing fluid should be reconsidered to avoid&#xD;
      these undesirable effects in pediatric surgery.&#xD;
&#xD;
      Our study aims to identify an appropriate use of 5% dextrose containing solution during&#xD;
      intraoperative period in children (2 age groups: 1-2 vs 3-5 years old) that can prevent&#xD;
      glucose and lipid mobilization without causing hypo/hyperglycemia and provide adequate fluid&#xD;
      maintenance in the context of hospitals in Thailand&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  In this randomized controlled trial, the investigator will find the difference in pre&#xD;
           and postoperative value of base excess among the different fluid groups which is an&#xD;
           acid-base parameter indicating volume status and mobilization of lipid stores in each&#xD;
           age group (2 age group: 1-2 vs 3-5 years old). Each age group will be divided to:&#xD;
&#xD;
             1. Group D0: patients will receive Acetate Ringer's solution (Acetar) infused at&#xD;
                maintenance rate&#xD;
&#xD;
             2. Group D1: 5%dextrose in normal saline (5%DNSS) infused ¼ of maintenance rate&#xD;
                [resulted in 1.25%dextrose equivalence]&#xD;
&#xD;
             3. Group D2: 5%DNSS infused ½ of maintenance rate [resulted in 2.5%dextrose&#xD;
                equivalence]&#xD;
&#xD;
             4. Group D5: 5%DNSS infused with maintenance rate&#xD;
&#xD;
        -  Patient will be fasting as standard preoperative fasting protocol, and received 5 ml/kg&#xD;
           of water at 3 hours prior to surgery&#xD;
&#xD;
        -  After standard anesthesia induction and intravenous line (IV) placement, the blood&#xD;
           samples will be collected and the POCT glucose will be re-evaluated every 1 hour through&#xD;
           the operation to avoid intraoperative hypo/hyperglycemia.&#xD;
&#xD;
        -  The first blood sample will be collected after IV line placement and the second blood&#xD;
           sample will be collected at the end of surgery. Both blood samples will be sent to the&#xD;
           lab to measure blood glucose, serum electrolytes (sodium, potassium, and chloride),&#xD;
           acid-base parameters (pH, base excess, standardized bicarbonate, anion gap), endocrine&#xD;
           parameters (serum insulin, glucagon, cortisol), and metabolic parameters (free fatty&#xD;
           acid, serum ketone, serum lactate).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference in pre and postoperative value of base excess</measure>
    <time_frame>1 day</time_frame>
    <description>To find the difference in pre and postoperative value of base excess among the different fluid groups which is an acid-base parameter indicating volume status and mobilization of lipid stores in each age group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference in postoperative value of other acid-base, metabolic, and endocrine parameters</measure>
    <time_frame>1 day</time_frame>
    <description>To find the difference in postoperative value of other acid-base, metabolic, and endocrine parameters that indicate mobilization of glucose and lipid stores of each group with different maintenance rate of fluid in each age group and between age group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postoperative base excess value that equal or more negative than -5 of each group</measure>
    <time_frame>1 day</time_frame>
    <description>To find the incidence of postoperative base excess value that equal or more negative than -5 of each group with different maintenance rate of fluid in each age group and between age group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The difference in perioperative blood glucose level among the groups</measure>
    <time_frame>1 day</time_frame>
    <description>To find the difference in perioperative blood glucose level among the groups measured during surgery of each group with different maintenance rate of fluid in each age group and between age group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypotension of each group</measure>
    <time_frame>1 day</time_frame>
    <description>To find the incidence of hypotension of each group with different maintenance rate of fluid in each age group and between age group</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>Pediatric Surgery</condition>
  <arm_group>
    <arm_group_label>Dextrose0</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acetate Ringer's solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.25%dextrose equivalence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5%dextrose equivalence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dextrose5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>5%dextrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer acetate</intervention_name>
    <description>Patient will receive Acetate Ringer's solution (Acetar) infused at maintenance rate</description>
    <arm_group_label>Dextrose0</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1.25%Dextrose equivalence</intervention_name>
    <description>5%dextrose in normal saline (5%DNSS) infused ¼ of maintenance rate</description>
    <arm_group_label>Dextrose1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2.5%Dextrose equivalence</intervention_name>
    <description>5%dextrose in normal saline (5%DNSS) infused ½ of maintenance rate</description>
    <arm_group_label>Dextrose2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextrose 5</intervention_name>
    <description>5%dextrose in normal saline (5%DNSS) infused with maintenance rate</description>
    <arm_group_label>Dextrose5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Children aged of 1 to 5 years&#xD;
&#xD;
          2. ASA physical status 1 and 2&#xD;
&#xD;
          3. Schedule for elective non-abdominal surgery between 1-3 hours under general anesthesia&#xD;
             without anticipation of major blood loss at Siriraj Hospital.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients with severe neurologic, cardiac, endocrine, or metabolic disease&#xD;
&#xD;
          2. Patients receiving intravenous fluid preoperatively&#xD;
&#xD;
          3. Patients with history or have known risk of hypoglycemia&#xD;
&#xD;
          4. Patient with severe liver dysfunction&#xD;
&#xD;
        Withdrawal or termination criteria&#xD;
&#xD;
          1. Patients requiring intraoperative blood product transfusion or inotropes infusion&#xD;
&#xD;
          2. Patients who have preoperative hypoglycemia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patcharee Sriswasdi, MD</last_name>
    <phone>+66815500123</phone>
    <email>pat.si.research@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Siriraj Hospital</name>
      <address>
        <city>Bangkok noi</city>
        <state>Bangkok</state>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Nilsson K, Larsson LE, Andréasson S, Ekström-Jodal B. Blood-glucose concentrations during anaesthesia in children. Effects of starvation and perioperative fluid therapy. Br J Anaesth. 1984 Apr;56(4):375-9.</citation>
    <PMID>6712852</PMID>
  </reference>
  <reference>
    <citation>Barua K, Rajan S, Paul J, Tosh P, Padmalayan A, Kumar L. Effect of Using Ringer's Lactate, with and without Addition of Dextrose, on Intra-Operative Blood Sugar Levels in Infants Undergoing Facial Cleft Surgeries. Anesth Essays Res. 2018 Apr-Jun;12(2):297-301. doi: 10.4103/aer.AER_53_18.</citation>
    <PMID>29962586</PMID>
  </reference>
  <reference>
    <citation>Suraseranivongse S, Attachoo A, Leelanukrom R, Chareonsawan U, Horatanaruang D. National survey of pediatric anesthesia practice in Thailand. J Med Assoc Thai. 2011 Apr;94(4):450-6.</citation>
    <PMID>21591530</PMID>
  </reference>
  <reference>
    <citation>Sieber FE, Smith DS, Traystman RJ, Wollman H. Glucose: a reevaluation of its intraoperative use. Anesthesiology. 1987 Jul;67(1):72-81.</citation>
    <PMID>3111308</PMID>
  </reference>
  <reference>
    <citation>Lanier WL, Stangland KJ, Scheithauer BW, Milde JH, Michenfelder JD. The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: examination of a model. Anesthesiology. 1987 Jan;66(1):39-48.</citation>
    <PMID>3800033</PMID>
  </reference>
  <reference>
    <citation>Nishina K, Mikawa K, Maekawa N, Asano M, Obara H. Effects of exogenous intravenous glucose on plasma glucose and lipid homeostasis in anesthetized infants. Anesthesiology. 1995 Aug;83(2):258-63.</citation>
    <PMID>7631946</PMID>
  </reference>
  <reference>
    <citation>Sümpelmann R, Becke K, Crean P, Jöhr M, Lönnqvist PA, Strauss JM, Veyckemans F; German Scientific Working Group for Paediatric Anaesthesia. European consensus statement for intraoperative fluid therapy in children. Eur J Anaesthesiol. 2011 Sep;28(9):637-9. doi: 10.1097/EJA.0b013e3283446bb8.</citation>
    <PMID>21654319</PMID>
  </reference>
  <reference>
    <citation>Datta PK, Pawar DK, Baidya DK, Maitra S, Aravindan A, Srinivas M, Lakshmy R, Gupta N, Bajpai M, Bhatnagar V, Agarwala S. Dextrose-containing intraoperative fluid in neonates: a randomized controlled trial. Paediatr Anaesth. 2016 Jun;26(6):599-607. doi: 10.1111/pan.12886. Epub 2016 Apr 16.</citation>
    <PMID>27083135</PMID>
  </reference>
  <reference>
    <citation>HOLLIDAY MA, SEGAR WE. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957 May;19(5):823-32.</citation>
    <PMID>13431307</PMID>
  </reference>
  <reference>
    <citation>Davis JW, Shackford SR, Mackersie RC, Hoyt DB. Base deficit as a guide to volume resuscitation. J Trauma. 1988 Oct;28(10):1464-7.</citation>
    <PMID>3172306</PMID>
  </reference>
  <reference>
    <citation>Beath SV. Hepatic function and physiology in the newborn. Semin Neonatol. 2003 Oct;8(5):337-46. Review.</citation>
    <PMID>15001122</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>patcharee sriswasdi</investigator_full_name>
    <investigator_title>MD, MPH</investigator_title>
  </responsible_party>
  <keyword>Glucose containing solution</keyword>
  <keyword>Dextrose containing solution</keyword>
  <keyword>Dextrose-saline solution</keyword>
  <keyword>Pediatric fluid</keyword>
  <keyword>Pediatric hyperglycemia</keyword>
  <keyword>Pediatric hypoglycemia</keyword>
  <keyword>Intraoperative glucose</keyword>
  <keyword>Intraoperative fluid</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

